Norsk Hydro, A.s.

Norskhydro Asa

Rolf O Larsen

John M Dornish

Bernt Borretzen

Erik O Pettersen

Reidar Oftebro

Thomas Ramdahl

Steinar Pedersen

Kari-Anne Leth-Olsen

Bernt Bo Slashedrretzen

Vidar Moen

Øystein Paulsen

Erick O Pettersen

Bård Sæthre

Reider Oftebro

Rolf Oftebro

The present invention concerns large spherical polymer particles with a narrow size distribution and a procedure for producing such particles. The procedure is characterized in that a seed polymerization is performed in which the start particles have a very high ability to absorb new monomer so that finished particles are obtained after only one stage of polymerization even if the finished particles are to be as large as in the range 10 to 100 &#x3bc;m. The procedure is also characterized in that, when porous particles are produced, a porous structure can be formed in which the fraction of micropores is insignificant. Another characteristic feature of the procedure is that the size distribution of the finished particles is narrow and in some cases narrower than in the start particles.

Single stage seed polymerization for the production of large polymer particles with a narrow size distribution

Pharmaceutical compositions

New compounds having the general formula I ##STR1## wherein Y may be H or D; and A is H, D, alkyl with 1-4 C-atoms, halogen, nitro, amino, monoalkyl amino or dialkyl amino wherein the alkyl groups have 1-4 C atoms or OR wherein R is H or alkyl of 1-4 C-atoms;

Acetal derivatives of aromatic aldehydes

New compounds of formula I: ##STR1## wherein Y may be CN or ##STR2## wherein A may be H, D, alkyl with 1-4 carbon atoms, OR wherein R is H or alkyl with 1-4 carbon atoms, or --NR.sub.1 R.sub.2 or --CR.sub.1 R.sub.2 R.sub.3 wherein R.sub.1, R.sub.2 and R.sub.3 are the same or different and are H or alkyl with 1-4 carbon atoms;

Deuterated benzaldehydes

Deuterated aromatic aldehydes of the formula: ##STR1## where Ar is substituted phenyl, and derivatives thereof represented by the formula: ##STR2## where Ar is substituted or unsubstituted phenyl, and X.sub.1 and X.sub.2 are substituted hetero atoms or together with the carbon to which they are attached form a heterocycle. These compounds are useful as anticancer and analgesic agents.

Deuterated compounds

The use of L-ascorbic acid, or a pharmaceutically acceptable salt thereof, in combination with 5,6-O-benzylidene-L-ascorbic acid, or 5,6-O-benzylidene-L-ascorbic acid deuterated at least at the 1-position of the aldehyde group of the benzylidene moiety, or a pharmaceutically acceptable salt of such acids, results in a synergistically enhanced cytotoxicity on human carcinoma cells.

Pharmaceutical compositions with anti-cancer activity against carcinoma

Anti-cancer platinum complexes such as cisplatin exhibit a synergistically higher level of anti-tumour activity when administered substantially simultaneously either with L-ascorbic acid, or with 5,6-O-benzylidene-L-ascorbic acid or deuterated forms thereof.

Pharmaceutical compositions with anit-cancer activity and method for the

Anti-cancer platinum complexes such as cisplatin exhibit a synergistically high level of anti-tumor activity when administered substantially simultaneously either with L-ascorbic acid, or with 5,6-O-benzylidene-L-ascorbic acid or deuterated forms thereof.

Pharmaceutical compositions with anti-cancer activity and method for the

Activity against carcinoma and method for the treatment of carcinoma

Deuterated aromatic aldehydes of the formula: ##STR1## where Ar is substituted phenyl, and derivatives thereof represented by the formula: ##STR2## where Ar is substituted or unsubstituted phenyl, and X.sub.1 and X.sub.2 are substituted hetero atoms or together with the carbon to which they are attached from a heterocycle. These compounds are useful as anticancer agents.

Growing community of inventors

Porsgrunn, Norway

Rolf O Larsen